Marijuana News in Arizona and World
The recent debate surrounding the DEA rescheduling marijuana will at least lead to more research becoming possible. Research on specific, the naturally-occurring chemicals in cannabis, will be the primary focus for researchers. Since cannabinoids mirror natural chemicals already in the body, researchers are interested in the way that they are released in the body.
Additional changes will allow smaller, private companies to grow and test cannabis, according to The Denver Post. For profit companies may develop marijuana-based medicines that would undergo FDA approval for distribution. This is the first time that marijuana will be able to be grown by more than just accredited universities.
University of Colorado chemistry professor, Robert Sievers, said, “I regard this as a red-letter day. If things work as they should, this will be the first day of a cannabinoid pharmaceutical industry.”
The process of growing marijuana for research purposes is not as easy as having an application approved. The application process takes several years due to inspections and the significant amount of security equipment required.
CU Skaggs School of Pharmacy and Pharmaceutical Science, Dr. Jacci Bainbridge, said, “So, it seems like they’re giving us a little leeway, but there are still so many barriers you have to get over.”
Issues surrounding potency and precise chemical compositions make it difficult for scientists to do their job. Brookings Institution senior fellow John Hudak said, “They either scrap the study or they change the study to meet what the supply can offer. And that’s not good science.”
Following the DEA’s announcement, it was said that the DEA has a goal to diversify the marijuana that is available for research. If marijuana-derived experimental logs become important, reclassification may take place. It would occur due to additional research being conducted and proof of medical benefits from marijuana.
Some are hoping that increased research will start to breakdown all or some of the prohibition laws.
DEA spokesperson Russell Baer did say that, “Parts of it could definitely move. And I believe that’s kind of the direction this is moving toward.”
Sievers has been waiting for several years to research marijuana. He said, “There so many people who are interested in so many ways in what the promise could be. But, I think everybody is also looking over their shoulders.”
Following a tough loss over the weekend at UFC 202, UFC fighter Nate Diaz won the hearts of medical marijuana advocates by hitting a cannabidiol () vape pen during his post-match interview.
In Nevada, and the UFC, all MMA Junkie.(the naturally occurring chemicals in cannabis) are banned in competition. However, just hours after a fight is over, so is the “in-competition” phase, which allowed Diaz the ability to legally hit is vape pen, according to
Nate Diaz, and his brother Nick, are both UFC fighters and supporters of CBD use for athletes. If urine samples are collected within the 6-hour in-competition period and the sample comes back with even a trace of CBD in it, it could violate the anti-doping policies in place by the Nevada State Athletic Commission and the UFC.
Attorney Erik Magraken said, “Assuming Nate Diaz provided a post bout sample to the NSAC (assuming they wished to collect one) before vaping and assuming that sample comes back negative then this escapade will not amount to an NSAC anti-doping violation.”
Magraken also said, “Interestingly, if USADA wishes to collect a sample in the hours following vaping, depending on the substance being ingested, Nate’s choice may prove problematic.”
Diaz, when speaking about his CBD oil use, points out that CBD does not cause psychoactive effects like, and only provides medicinal benefits.
A new ordinance introduced in Nashville, Tennessee, would decriminalize possession of small amounts of marijuana. The current penalties for possession in Nashville entail up to six years in jail and up to $5,000 in fines for possessing just half an ounce or less of marijuana. City council members agree that charges like this can ruin people’s lives.
If the ordinance passes, offenders would receive a civil offense citation resulting in a $50 ticket and a set amount of community service, according to WRCB. Metro police reported 18,000 marijuana-related arrests in the past 18 months. Most of those arrests were misdemeanors.
Mayor Megan Barry is reviewing the ordinance. A former state trooper and a council member sponsor the bill. Mayor Barry claims to generally support the ordinance.
Today, August 19, a Maricopa County Superior Court judge dismissed a lawsuit filed by opponents of Proposition 205, the Regulation and Taxation of Marijuana Act, who were attempting to keep the initiative off the November ballot.
The Campaign to Regulate Marijuana Like Alcohol in Arizona, which supports Prop 205, is asking Maricopa County Attorney Bill Montgomery and Yavapai County Attorney Sheila Polk, who were plaintiffs in the lawsuit, to accept the court’s ruling and focus on fighting serious crimes instead of citizen initiatives.
“We are pleased with the court’s ruling and that Arizona voters will be able to exercise their right to vote on Proposition 205,” said J.P. Holyoak, CRMLA Campaign Chairman. “This was a frivolous and politically motivated lawsuit. If these county prosecutors dislike this ballot measure, they should take their arguments to the voters, not to our overburdened court system. We hope they will accept the court’s ruling and return to waging legal battles against dangerous criminals rather than citizen initiatives.”
If passed, Prop 205 will allow adults 21 and older to possess limited amounts of marijuana, establish a government-regulated system in which marijuana is regulated similarly to alcohol, and enact a 15-percent tax on retail marijuana sales. A majority of the tax revenue would be directed to Arizona schools and other education programs.
“Roughly 84 years ago, it was the voters who put an end to the failed policy of alcohol prohibition in Arizona,” Holyoak said. “Today’s ruling confirmed they will have the opportunity to end an equally disastrous prohibition policy this November.”
The DEA decided against rescheduling or descheduling marijuana last week, so it will remain on the Controlled Substances Act as a Schedule I drug. But now, Hillary Clinton is saying that she plans to reschedule marijuana if she is elected.
Clinton’s announcement is a direct response to the DEA’s failure to reschedule marijuana, according to SF Gate. Although, the one thing that the DEA did do was reduce restrictions on marijuana research.
Clinton’s plans are to reschedule marijuana as a Schedule II substance. This would acknowledge marijuana as medicine for treating chronic health conditions.
Clinton’s senior policy advisor, Maya Harris said, “Marijuana is already being used for medicinal purposes in states across the country, and it has the potential for even further medical use. As Hillary Clinton has said throughout this campaign, we should make it easier to study marijuana so that we can better understand its potential benefits, as well as its side effects.”
Harris also said, “As president, Hillary will build on the important steps announced today by rescheduling marijuana from a Schedule I to a Schedule II substance. She will also ensure Colorado, and other states that have enacted marijuana laws, can continue to serve as laboratories of democracy.”
Healthcare, law, politics, pro sports, investment opportunities, business and consumer trends, entrepreneurs and startups are among the many national cannabis industry hot topics that will be covered at the upcoming Arizona Cannabis Conference and Expo.
The event will be in downtown Phoenix at the Phoenix Convention Center on Saturday, October 15 and Sunday, October 16. Admission is $50 each day.
Along with marijuana industry professionals speaking, there will be more than 300 businesses, non-profit organizations and budding entrepreneurs at the expo.
Organizers say the Arizona Cannabis Conference and Expo is expected to draw nearly 10,000 attendees from across Arizona and the nation to learn about the blooming industry.
“We have created national demand for our shows because they uniquely merge business, education and entertainment. They allow participants to reach medical patients, mainstream consumers, and business-to-business professionals. Attendees can learn directly from industry leading doctors, scientists, , finance experts and even their favorite former NFL gridiron heroes,” said an spokesperson.
This week a federal appeals court in San Francisco banned the Justice Department from prosecuting cases where medical marijuana patients are not in violation of any state laws.
Congress barred the Justice Department from using funds to prevent individual states from having their own regulations for medical marijuana, according to The Washington Post, Some federal prosecutors argued that actions taken by Congress still allow the DEA and DOJ to prosecute individuals for federal marijuana law violations. That argument was rejected by the court. The court reminded those prosecutors that federal interference with state-regulated medical marijuana programs hinders he state’s ability to enforce their individual regulations.
Marijuana industry attorney Marc Zilversmit said, “This is the beginning of the end of federal prosecutions of state medical marijuana dispensary operators, growers and patients.”
Judge Diarmuid F. O’Scannlain wrote, “If DOJ wishes to continue these prosecutions, Appellants are entitled to evidentiary hearings to determine whether their conduct was completely authorized by state law, by which we mean that they strictly complied with all relevant conditions imposed by state law on the use, distribution, possession, and cultivation of medical marijuana.”
An appeal by federal prosecutors regarding this ruling could occur once the Justice Department reviews the complete language of the decision.
Representative Earl Blumenauer of Oregon said, “DOJ has been a little slow to pick up on lawmakers’ desire that prosecutors go after organized drug rings and leave alone medicinal pot sellers and users.”
Most scientists admit that studying marijuana is safe, and that researching it shouldn’t be such an arduous process.
Gregory Gerdeman, an Assistant Professor of Biology at Eckerd College, told TIME: “A question that is not on the lips of researchers is whether or not the consumption of cannabis-based medicines is safe… in the biomedical research community, it is universally understood that cannabis is a very safe, well-tolerated medicine.”
Here are the main scientific issues that researchers told TIME they want to understand about marijuana:
Is marijuana an effective cancer therapy?
“It is already widely understood that marijuana is valuable and safe as a palliative medicine, which undermines the tenets of the Schedule 1 status,” says Gerdeman. “But additionally, there are anecdotal patient reports, increasing numbers of legitimate clinical case studies, and large amounts of preclinical studies that all indicate tumor-fighting activities of, and with great mechanistic detail.” Gerdeman says he wants to know whether herbal marijuana is effective in cancer therapy, and if it is, for what cancer types.
What does it do to the brain?
Studies have shown small structural changes in the brains of people who use marijuana, and researchers say there is little doubt that using marijuana has effects on the brain. However, whether those changes are actually bad, remains unknown. “This is an important question with tremendous policy implications,” says Gerdeman. “While the media interpret such [changes] de facto as evidence of damage, they are within the range of normal human variation as far as we currently understand.”
What dosage or strains have the best use in medicine?
Researchers say they want to know more about how much marijuana is needed to treat a person’s disorder, and for how long. “Like all drugs, FDA-approved therapeutics or recreational, marijuana will have some unwanted side effects,” says Sinai’s Hurd. In addition, researchers are still looking into what strains are most beneficial and whether a person needs the whole plant, or just one compound.
Can marijuana help brain and cognitive problems?
Some researchers, like Gerdeman, want to study whether marijuana could stave off Alzheimer’s disease or even mitigate brain damage from stroke or concussions. One 2014 study suggested a compound in marijuana could slow the production of proteins that accumulate when a person has Alzheimer’s.
What about anxiety?
There’s some evidence suggesting marijuana could help people with anxiety, but the relationship is still not well understood. “Without the clinical trials it may be a long time before we know for sure,” says Patel.
Can pot help end the opioid epidemic?
As TIME has previously reported, several doctors are interested in the use of marijuana as an alternative or adjunct to opioids, since the U.S. is currently in the midst of an epidemic of painkiller addiction. “If you give [opioids] alongside cannabis, there is a synergistic effect which means you can give less of the opioid and or you can give the opioid for a shorter period,” says Dr. Lester Grinspoon is Associate Professor Emeritus of Psychiatry at Harvard Medical School. A 2016 study found doctors in a state where marijuana was legal prescribed an average of 1,826 fewer doses of painkillers per year.
Are there long term consequences of using pot?
Scientists also want to understand whether marijuana can cause any effects over the long term, since some people may use the plant medicinally for some time. “What are the effects on the developing brain?,” says Hurd. “This is a particularly important question for me since our preclinical studies suggested that prenatal and adolescentexposure can have long-term impact into adulthood long after the drug was administered.”
The medical marijuana program in New York has been up and running for eight months. But the challenging and restrictive process of qualifying for a medical marijuana card has led to low patient numbers. Furthermore, there are not enough dispensary locations, only five statewide, to dispense medicine to approved patients.
Three licensed dispensaries have not made any money, Ibtimes.com reports. Etain Health, PharmaCann and Vireo Health of New York confirmed those claims. Columbia Care NY and Bloomfield Industries, Inc. declined to comment on their finances.
Electrum Partners founder Leslie Bocskor said in an interview that, “No matter how hard you look, there’s no path, there’s no way to make money in any way. The Program is just so hamstrung as to make it impossible, from my perspective, to find any path to profitability.”
Bocskor declined to invest in a New York marijuana business and said it was “because we just didn’t think that the risk/reward was there for us.”
Numbers reported on July 26 display that New York only has 6,000 approved medical marijuana patients. There are only 639 registered doctors statewide. Patients only have access to 5 types of marijuana oils; no flower or other medical marijuana products are available.
Etain COO Hillary Peckham said, “We’re still having a lot of challenges, and there’s still a huge amount of cost associated with just one operating – it’s still a slower growth than we’d like to see overall. The really positive part is this is now being open for seven, eight months, we’ve been able to see recurring patients and the benefits they are having.”
Many prospective medical marijuana patients have complained about the inability to gain approval to use medical marijuana. Some blame Governor Cuomo for insisting on such a restrictive program to be in place.
Assemblyman Richard Gottfried said, “Unfortunately the program has gotten off to a very slow start, and I think that is because the governor insisted on the law being very restrictive.”
One determined ultrarunner proved that marijuana does not make you lazy or unproductive, but it actually assists with exercise. After consuming marijuana, Avery Collins, successfully ran 200 miles.
The human body has an endocannabinoid system, so it is already wired to work with marijuana. Endocannabinoids regulate physiological functions like metabolism, energy, stress, mood, pain, appetite, and sleep.
The endogenous receptors, lipids, and enzymes in the body work with the Motherboard reports. Collins says that, “It’s pretty simple. I enjoy going on runs when I’m high.” He is an athlete, but does not use marijuana when competing, only while practicing and training.in marijuana,
Collins also stated that, “[Cannabis] helps me live right in the moment. It makes things very spiritual. You don’t think about anything except the run itself. I use it as a way to intensify and enhance the run. It makes the longevity of the runner’s high last longer because technically you’re already high.”
Collins also uses marijuana to help relieve sore muscles. Because runners are drug tested, Collins makes sure to stop using marijuana in enough time to pass the drug test so he can participate in his long endurance runs, which average 100 – 200 miles each.
While no scientific connection proves that using marijuana before a run improves performance, Collins benefits from its medicinal properties such as helping him sleep, recovering from sore muscles, training while sore and staying motivated to finish a training session.
Collins currently has three marijuana industry sponsors.
Collins concluded by saying, “Everybody likes to overanalyze it. I’m not looking for any kind of advantage. I like being high and going on runs. It’s fun, it’s freeing, and it’s a good opportunity to escape from the rest of the world.”